This community-based qualitative inquiry asks: what is the meaning and impact of taking psychiatric medications in the lives of people with severe mental illness living in a residential program. Participants were twenty-one adults with extensive histories of mental illness, numerous hospitalizations, currently taking multiple medications. In addition to a thematic analysis of semi-structured interviews, participants each created a color drawing related to their experience with medication, which they titled and ‘interpreted’ themselves (see http://blog.vcu.edu/kbentley/). The main finding is a distillation of themes into a seven dimension typology of the meaning. A staff-resident Advisory Panel guided the research, and final results take into account participant feedback and member checking. Included here are plans and hopes for using the findings to enhance specific programming at the residential program to better reflect the role and importance of medication issues in the everyday lives of residents.
Adelman, S.A. ( 1985) ‘Pills as Transitional Objects: A Dynamic Understanding of the Use of Medication in Psychotherapy’, Psychiatry48: 246-53.
2.
Auerbach, C.F. and Silverstein, L.B. ( 2003) Qualitative Data: An Introduction to Coding and Analysis. NYNYU Press.
3.
Awad, A.G. ( 1993) ‘Subjective Response to Neuroleptics in Schizophrenia’ , Schizophrenia Bulletin19: 609-18.
4.
Awad, A.G., Voruganti, L.N., Heslegrave and Hogan, T.P. (1996) ‘Assessment of the Patient’s Subjective Experience in Acute Neuroleptic Treatment: Implications for Compliance and Outcome’, International Clinical Psychopharmacology1(Suppl. 2): 55-9.
5.
Bentley, K.J. and Collins, K.S. ( 2006) ‘Psychopharmacological Treatment for Child and Adolescent Mental Disorders’, in Franklin C.,Harris M. B. and Allen-Meares P. (eds) The School Services Sourcebook: A Guide for Social Workers, Counselors, and Mental Health Professionals. New York: Oxford University Press, 15-30.
6.
Bentley, K.J. and Walsh, J. ( 2006) The Social Worker and Psychotropic Medication; Toward Effective Collaboration with Mental Health Clients, Families and Providers . Belmont: CA: Wadsworth.
7.
Bentley, K.J., Walsh, J. and Farmer, R. ( 2005a) ‘Roles and Activities of Clinical Social Workers in Psychopharmacotherapy: Results of a National Survey’, Social Work50(4): 295-303.
8.
Bentley, K.J., Walsh, J. and Farmer, R. ( 2005b) ‘Referring Clients for Psychiatric Medication: Best Practices for Social Workers’, Best Practices in Mental Health1(1): 59-71.
9.
Blumer, H. ( 1969) Symbolic Interactionism: Perspective and Method. Englewood Cliffs, NJ: Prentice-Hall.
10.
Bradley, S. ( 1990) ‘Non-Physician Psychotherapist-Physician Pharmacotherapist: A New Model for Concurrent Treatment’, Psychiatric Clinics of North America13(2): 307-22.
11.
Brody, H. ( 1988) ‘The Symbolic Power of the Modern Personal Physician: The Placebo Response Under Challenge’, The Journal of Drug Issues18(2): 149-61.
12.
Carder, P.C., Vuckovic, N. and Green, C.A. ( 2003) ‘Negotiating Medications: Patient Perceptions of Long-term Medication Use’, Journal of Clinical Pharmacy and Therapeutics28: 409-17.
13.
Corin, E. ( 1998) ‘The Thickness of Being: Intentional Worlds, Strategies of Identity, and Experience Among Schizophrenics’, Psychiatry61(2): 133-46.
14.
Davidson, L. and Strauss, J.S. ( 1992) ‘Sense of Self in Recovery From Severe Mental Illness’ , British Journal of Medical Psychology65: 131-45.
15.
Dziegielewski, S.F. and Leon, A.M. ( 2001) Social Work Practice and Psychopharmacology. NY: Springer.
16.
Estroff, S.E. ( 1981) Making it Crazy: An Ethnography of Psychiatric Patients in an American Community. Berkeley: University of California Press.
17.
Estroff, S.E. ( 1989) ‘Self, Identity, and the Subjective Experience of Schizophrenia: In Search of the Subject’, Schizophrenia Bulletin15: 189-96.
18.
Floersch, J. ( 2003) ‘The Subjective Experience of Youth Psychotropic Experience’, Social Work in Mental Health1(4): 51-69.
19.
Floersch, J., Townsend, L., Munson, M., Winbush, V., Kranke, D., Faber, R., Thomas, J., Findling, R. and Jenkins, J. ( 2007) Adolescent Experience of Psychotropic Treatment. San Francisco, CA: Paper Presentation at the Society for Social Work and Research.
20.
Gabe, J. ( 1991) ‘Personal Troubles and Public Issues: The Sociology of Long-term Tranquilizer Use’, in Gabe J. (ed.) Understanding Tranquilizer Use: The Role of the Social Sciences. London: Routledge , 31-47.
21.
Garavan, J., Browne, S., Gervin, M., Lane, A., Larkin, C. and O’Callaghan, E. ( 1998) ‘Compliance with Neuroleptic Medication in Outpatients with Schizophrenia: Relationship to Subjective Response to Neuroleptics, Attitudes to Medication and Insight’, Comprehensive Psychiatry39(4): 215-19.
22.
Grbich, C. ( 2007) Qualitative Data Analysis: An Introduction. Los Angeles: Sage.
23.
Gutheil, T.G. ( 1977) ‘Improving Patient Compliance: Psychodynamics in Drug Prescribing’, Drug Therapy7: 82-3, 87, 89-91, 95.
24.
Hamilton, D.L., Devine, P.G. and Ostrom, T.M. ( 1994) ‘Social Cognition and Classic Issues in Social Psychology’ , in Devine P. G., Hamilton D. L. and Ostrom T. M. (eds) Social Cognition: Impact on Social Psychology. San Diego: Academic Press, 1-13.
25.
Hausner, R. (1985-6) ‘Medication and Transitional Phenomena’, International Journal of Psychoanalytic Psychotherapy11: 375-407.
26.
Helman, C.G. ( 1981) ‘ ‘‘Tonic’’, ‘‘Fuel’’ and ‘‘Food’’: Social and Symbolic Aspects of the Long-term Use of Psychotropic Drugs’, Social Science & Medicine15B: 521-33.
27.
Hyland, J. ( 1991) ‘Integrating Psychotherapy and Pharmacotherapy’ , Bulletin of the Menninger Clinic55(2): 205-15.
28.
Jenkins, J., Strauss, M.E., Carpenter, E.A., Miller, D., Floersch, J. and Sajatovic, M. ( 2005) ‘Subjective Experience of Recovery From Schizophrenia-related Disorders and Atypical Antipsychotics’, International Journal of Social Psychiatry51(3): 211-27.
29.
Kando, T.M. ( 1977). Symbolic interactionism. In Social interaction . St. Louis: C.V. Mosby Co., 104-129.
30.
Karuso, T.B. ( 1982) ‘Psychotherapy and Pharmacology: Toward an Integrative Model’, American Journal of Psychiatry139: 1102-13.
31.
Knudsen, P., Hansen, E.H., Traulsen, J.M. and Eskildsen, K. ( 2002) ‘Changes in Self-concept While Using SSRI Antidepressants’ , Qualitative Health Research12(7): 932-44.
32.
Layder, D. ( 1993) New Strategies in Social Research. Cambridge: Polity Press.
33.
Levy, S.T. ( 1977) ‘Countertransference Aspects of Pharmacotherapy in the Treatment of Schizophrenia’, International Journal of Psychoanalytic Psychotherapy6(1): 15-30.
34.
Lindesmith, A.R., Strauss, A.L. and Denzin, N.K. ( 1991) Social Psychology, 7th edn. Englewood Cliffs, N.J.: Prentice-Hall .
35.
Mintz, D. ( 2005) ‘Teaching the Presciber’s Role: The Psychology of Psychopharmacology’, Academic Psychiatry29(2): 187-94.
36.
Mintz, D. ( 2002) ‘Meaning and Medication in the Care of Treatment-resistant Patients’, American Journal of Psychotherapy56(3): 322-37.
37.
Nevins, D.B. ( 1990) ‘Psychoanalytic Perspectives on the Use of Medication for Mental Illness’, Bulletin of the Menninger Clinic54(3): 323-9.
38.
Pellegrino, E.D. ( 1976) ‘Prescribing and Drug Ingestion Symbols and Substances’ , Drug Intelligence and Clinical Pharmacy10: 624-30.
39.
Powell, A.D. ( 2001) ‘The Medication Life’, Journal of Psychotherapy Practice and Research10(4): 217-22.
40.
Rappaport, N. and Chubinsky, P. ( 2000) ‘The Meaning of Psychotropic Medications for Children, Adolescents, and Their Families’, Journal of the American Academy of Child & Adolescent Psychiatry39(9): 1198-1200.
41.
Rhodes, L.A. ( 1984) ‘ ‘‘This Will Clear Your Mind’’: The Use of Metaphors for Medications in Psychiatric Settings’, Culture , Medicine and Psychiatry8: 49-70.
42.
Rogers, A., Day, J.C., Williams, B., Randall, F., Wood, P., Healy, D. and Bentall, R.P. ( 1998) ‘The Meaning and Management of Neuroleptic Medication: A Study of Patients With a Diagnosis of Schizophrenia’, Social Science & Medicine47: 1313-23.
43.
Sarwer-Foner, G.J. ( 1975) ‘Psychiatric Symptomatology: Its Meaning and Function in Relation to the Psychodynamic Action of Drugs’, in Denbar H.C.B. (ed.) Psychopharmacological treatment: Theory and Practice. NY: Marcel Dekker, 201-24.
Sells, D.J., Staynor, D.A. and Davidson, L. ( 2004) ‘Recovering the Self in Schizophrenia: An Integrative Review of Qualitative Studies’, Psychiatric Quarterly75(1): 87-97.
46.
Shapiro, A.K. ( 1959) ‘The Placebo Effect in the History of Medical Treatment’ , American Journal of Psychiatry116: 298-304.
47.
Usher, K. ( 2001) ‘Taking Neuroleptic Medications as the Treatment for Schizophrenia: A Phenomenological Study’, Australian and New Zealand Journal of Mental Health Nursing10: 145-55.
